Lu Jiade
Professor、
Doctor's introduction
Doctor of Medicine, Master of Management, Professor, National High-level Introduced Talent, National Distinguished Expert, Chief Scientist of the Key Research and Development Program of the Ministry of Science and Technology, Former Executive Vice President of Shanghai Proton Heavy Ion Hospital, Vice President of the National University of Singapore Hospital, Member of the Management Committee of Heyou International Hospital Group, Vice President of Heyou Hospital, Director of the Oncology Medical Center, Director of the Heyou Proton Heavy Ion Center. Be good at precise and accurate radiotherapy and multidisciplinary comprehensive treatment of tumors. Have authority in the diagnosis and treatment of head and neck, central nervous system tumors, and digestive tract tumors. Edited many oncology textbooks and guidelines, and published and distributed globally.
Be good at
Clinical and research on radiotherapy and comprehensive treatment of cancers such as head and neck, lung cancer and gastrointestinal tract.
Academic results
- Chief Editor of the Springer Series of Radiotherapy Oncology Guidelines;
- The lead person and chief scientist of the key research and development program project of the Ministry of Science and Technology;
- Currently serving as the chief editor of “Medical Radiology: Oncology Radiotherapy” and “Practice Guidelines for Oncology Radiotherapy” series. Among them, nearly 10 guidelines for oncology radiotherapy have been formulated through the “Practice Guidelines for Oncology Radiotherapy”;
- Has successively edited and published 14 Chinese and English monographs and textbooks such as “Radiation Oncology: An Evidence-Based Approach”;
- Edited and published many Chinese oncology monographs such as “Progress in the Treatment of Common Malignant Tumors”, “Series of Progress in the Diagnosis and Treatment of Common Malignant Tumors”, and “Series of Progress in the Diagnosis and Treatment of Common Malignant Tumors - Nasopharyngeal Carcinoma”.
- In recent years, more than 100 papers have been published in domestic and foreign core medical journals including Journal of Clinical Oncology, Cancer, Head and Neck, etc. (all are SCI or Chinese series journals).
